Breast Cancer Diagnostics Market 2020 | Global Trends, Share, Growth, Opportunity 2027 | By Kenneth Research

Global Breast Cancer Diagnostics Market is valued approximately USD 5.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020-2026. Breast cancer is a malignant tumor formed in the breast cells that can spread into the whole parts of the body. It is diagnosed with the use of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. At the initial stage, it can be diagnosed through certain screening tests such as yearly mammograms, MRI and CT scan. Increasing incidence of breast cancer among women, growing number of approvals for breast cancer diagnosis technologies, and favorable reimbursement framework for breast cancer diagnosis are the few factors responsible for high CAGR of the market over the forecast period. According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common form of cancer in women worldwide with an average 2million new cases being detected every year. American Cancer Research Society (ACRS) anticipates by 2030, that incident rate of breast cancer is expected to reach over 9.9 million cases with over 5.5 million annual deaths, primarily due to aging population. Similarly, as per the European Breast Cancer Coalition, incidence in the EU-28 in 2018 was estimated to be around 404,920. This, in turn, is anticipated to accelerate the demand of breast cancer diagnostics around the world. However, high installation cost of devices and side effects of radiation are the few factors expected to impede the growth of the market over the forecast period of 2020-2026.

Request For The Sample Report Here:

The regional analysis of global Breast Cancer Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high patient awareness, well-established diagnostic infrastructure, and the early adoption of technologically advanced imaging systems in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising incidence of breast cancer and rapidly improving healthcare infrastructure in the countries like China and India.

Major market player included in this report are:
Hologic Inc.
GE Healthcare
Phillips Healthcare
Fujifilm Holdings Corporation
Gamma Medica Inc.
Toshiba Corporation
Aurora Imaging Technology Inc.
Dilion Technologies Inc.
Genomic Health
NanoString Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Type:
Ionizing breast imaging technologies
Non-ionizing imaging technologies

By End-User:
Cancer research centers/institutes
Diagnostic Clinical laboratories
Ambulatory Surgical centers

By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Breast Cancer Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Click Here to Download Sample Report >>

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)
1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Diagnostics Market Dynamics
3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Breast Cancer Diagnostics Market, by Diagnostic Type
5.1. Market Snapshot
5.2. Global Breast Cancer Diagnostics Market by Diagnostic Type, Performance – Potential Analysis
5.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2016-2026 (USD Billion)
5.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
5.4.1. Ionizing breast imaging technologies
5.4.2. Non-ionizing imaging technologies
Chapter 6. Global Breast Cancer Diagnostics Market, by End-User
6.1. Market Snapshot
6.2. Global Breast Cancer Diagnostics Market by End-User, Performance – Potential Analysis
6.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
6.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Cancer research centers/institutes
6.4.3. Diagnostic Clinical laboratories
6.4.4. Ambulatory Surgical centers
Chapter 7. Global Breast Cancer Diagnostics Market, Regional Analysis
7.1. Breast Cancer Diagnostics Market, Regional Market Snapshot
7.2. North America Breast Cancer Diagnostics Market
7.2.1. U.S. Breast Cancer Diagnostics Market

About Kenneth Research:
Kenneth Research is a reselling agency which focuses on multi-client market research database. The primary goal of the agency is to help industry professionals including various individuals and organizations gain an extra edge of competitiveness and help them identify the market trends and scope. The quality reports provided by the agency aims to make decision making easier for industry professionals and take firm decisions which helps them to form strategies after complete assessment of the market. Some of the industries under focus include healthcare & pharmaceuticals, ICT & Telecom, automotive and transportation, energy and power, chemicals, FMCG, food and beverages, aerospace and defense and others. Kenneth Research also focuses on strategic business consultancy services and offers a single platform for the best industry market research reports.

Contact Us
Kenneth Research
Phone: +1 313 462 0911

Leonard Thomas is an energetic and versatile freelance writer for 5 years, he pen down any type of articles and web content. he is a Cambridge University Business English Certificate (Europe Level) holder . he is analytical, enthusiastic and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses .

Leave a Reply